We found that the high expression of LTF in tumors can promote mismatch repair, nucleotide excision repair, and other pathways, while the low expression of LTF is related to primary immunodeficiency, JAK/STAT signaling pathway, cancer pathway, PRAD, and other pathways’ enrichment. This evidence concerns the gene SOAT1 and inborn error of immunity.